Physician profile
Daniel C Bonis
NPI 1447261136
$19,367.08
in general payments reported to CMS, 2019-2025
33 companies · $1,091 in 2025
The $1,091 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,415 · 2020: $2,442 · 2021: $2,448 · 2022: $4,386 · 2023: $3,522 · 2024: $3,063 · 2025: $1,091.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,606 · Travel and Lodging: $70.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,605.81 |
| Travel and Lodging | $70.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,454.91 | 2019-2025 | Proclaim, Ionicrf, Octrode |
| Painteq LLC | $2,654.91 | 2021-2024 | Painteq |
| Relievant Medsystems, INC. | $1,246.13 | 2022-2023 | Intracept |
| Boston Scientific Corporation | $1,073.46 | 2019-2025 | Wavewriter Alpha Prime 16, Infinion 16, Intracept |
| Nalu Medical, INC. | $913.03 | 2024-2025 | Nalu Neurostimulation System |
| Spinal Simplicity, LLC | $430.27 | 2022-2025 | Ha Minuteman G3-R |
| Vertos Medical, INC. | $417.66 | 2022-2024 | Mild Device Kit |
| Curonix LLC | $394.41 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $291.50 | 2019 | |
| Pfizer INC. | $204.90 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $181.89 | 2021-2024 | Xtampza |
| Teva Pharmaceuticals USA, INC. | $142.72 | 2019 | |
| Foundation Fusion Solutions, LLC | $138.91 | 2020 | |
| Scilex Pharmaceuticals INC. | $124.26 | 2019-2021 | |
| Saluda Medical Americas, INC. | $119.38 | 2023-2024 | Evoke Scs, Evoke |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $91.99 | 2019-2021 | |
| Medtronic, INC. | $86.46 | 2021-2025 | Synchromedii |
| Medtronic USA, INC. | $53.23 | 2019-2020 | |
| Almatica Pharma LLC | $44.58 | 2022 | |
| Tersera Therapeutics LLC | $40.26 | 2019 | |
| Amgen INC. | $28.91 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $25.07 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.00 | 2022 | |
| Lundbeck LLC | $24.45 | 2022 | |
| Electronic Waveform Lab, INC. | $22.70 | 2021 | |
| Merz North America, INC. | $22.44 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $20.86 | 2021 | |
| Si-Bone, INC. | $19.26 | 2024 | |
| Lilly USA, LLC | $16.86 | 2021 | |
| Grt US Holding, INC. | $15.51 | 2022 | |
| Abbvie INC. | $14.35 | 2021 | |
| Indivior INC. | $14.05 | 2022 | |
| Depuy Synthes Sales INC. | $12.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Bonis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.